Status:

COMPLETED

MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS)

Lead Sponsor:

Erasme University Hospital

Conditions:

Diverticulum, Esophageal

Post Gastric Surgery Syndrome

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A novel magnetic device, called MAgnetic Gastrointestinal Universal Septotome (MAGUS) was designed to improve the Treatment of diverticulum of the esophagus, Pseudo-diverticulum of the upper GI tract,...

Detailed Description

In this study, the investigators aim at treating different pathological conditions, resulting in the appearance of a septum separating a healthy pathway and a pathological pouch. Food then stagnate in...

Eligibility Criteria

Inclusion

  • Age 18 years or older.
  • Patient has got evaluable symptoms (dysphagia, regurgitation, pain, weight loss, halitosis or others) associated with one of the following pathology:
  • Diverticulum of the esophagus;
  • A pseudo-diverticulum of the upper GI tract;
  • Candy cane syndrome;
  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

Exclusion

  • Refractory stenosis of the UGI proximal to the septum;
  • Septum height smaller than 2,5 cm or higher than 6 cm (check through CT scan, Barium Swallow or other imaging method);
  • Coagulation disorders;
  • Previous implantation of a magnetic-sensitive medical device (including active electronic implant, metallic stent, …);
  • Dysphagia related to motility disorder;
  • Planned MRI in the following month (30 days) of intervention.
  • Concurrent medical condition that would affect the investigator's ability to evaluate the patient's condition or could compromise patient safety;
  • Patient went through a surgery less than 8 weeks before implantation of the magnets;
  • Currently enrolled in another clinical trial.

Key Trial Info

Start Date :

February 19 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 15 2021

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT04480216

Start Date

February 19 2020

End Date

September 15 2021

Last Update

December 8 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hopital Erasme

Brussels, Belgium, 1070

MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS) | DecenTrialz